REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Imbaclinic Cia.Ltda (Ecuador)

Main Activities: Offices of Physicians
Full name: Imbaclinic Cia.Ltda Profile Updated: February 10, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Imbaclinic Cia.Ltda is based in Ecuador, with the head office in Ibarra. The company operates in the Offices of Physicians sector. It was established on September 18, 2014. 3 (2024) employees currently work for Imbaclinic Cia.Ltda. From the latest financial highlights, Imbaclinic Cia.Ltda reported a net sales revenue drop of 59.62% in 2024. Its’ total assets recorded a growth of 2.95%. The net profit margin of Imbaclinic Cia.Ltda decreased by 49.49% in 2024.

Headquarters
Cesar Morales Granda 476
Ibarra; Imbabura;

Contact Details: Purchase the Imbaclinic Cia.Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Imbaclinic Cia.Ltda report to view the information.
Registered Capital:
Purchase the Imbaclinic Cia.Ltda report to view the information.
Financial Auditors:
Purchase the Imbaclinic Cia.Ltda report to view the information.
Incorporation Date:
September 18, 2014
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
97%
Purchase this report to view the information.
3%
Company Performance
Financial values in the chart are available after Imbaclinic Cia.Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-59.62%▼
Total operating revenue
-59.62%▼
Operating profit (EBIT)
-94.97%▼
EBITDA
-94.97%▼
Net Profit (Loss) for the Period
-94.97%▼
Total assets
2.95%▲
Total equity
2.95%▲
Operating Profit Margin (ROS)
-49.49%▼
Net Profit Margin
-49.49%▼
Return on Equity (ROE)
-55.81%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo